Interaction Checker

Interacciones de Somatropina

Somatropina (Genotropin, Humatrope, Norditropin) tiene 83 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 23; moderadas: 60; leves: 0; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (23)

  • Azelastina y fluticasonaantihistamínicoGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • BeclometasonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • BetametasonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • BudesonidacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Budesonida y formoterolcorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • CiclesonidacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • ClobetasolcorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • DeflazacortcorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • DesonidacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • DexametasonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • FludrocortisonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • FlunisolidacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • FluocinonidacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • FluticasonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Fluticasona y salmeterolcorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • HalobetasolcorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • HidrocortisonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • MetilprednisolonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • MometasonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Olopatadina y mometasonaantihistamínicoGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • PrednisolonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • PrednisonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

  • TriamcinolonacorticosteroideGrave

    Intervention: Carefully adjust glucocorticoid dosing in pediatric patients receiving glucocorticoid treatments to avoid both hypoadrenalism and an inhibitory effect on growth. (etiqueta de Somatropina, Interacciones medicamentosas)

Interacciones moderadas (60)

  • AcarbosaantidiabéticoModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Alogliptinainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Alogliptina y metforminainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Bexagliflozinainhibidor de SGLT2Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Canagliflozinainhibidor de SGLT2Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Dapagliflozinainhibidor de SGLT2Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Dapagliflozina y metforminainhibidor de SGLT2Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Desogestrel y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Diacetato de etinodiol y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Drospirenona y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Dulaglutidaagonista del receptor de GLP-1Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Empagliflozinainhibidor de SGLT2Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Empagliflozina y metforminainhibidor de SGLT2Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • EstradiolestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Estradiol y dienogestanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Estradiol y noretisteronaestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Estrógenos conjugadosestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Estrógenos conjugados y bazedoxifenoestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Estrógenos esterificados y metiltestosteronaestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Etonogestrel y etinilestradiolestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Exenatidaagonista del receptor de GLP-1Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • FulvestrantestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • GlibenclamidasulfonilureaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Glibenclamida y metforminasulfonilureaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • GlimepiridasulfonilureaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • GlipizidasulfonilureaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Glipizida y metforminasulfonilureaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Insulina aspartainsulinaModerada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

  • Insulina degludecinsulinaModerada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

  • Insulina detemirinsulinaModerada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

  • Insulina glarginainsulinaModerada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

  • Insulina lisproinsulinaModerada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

  • Insulina regular (humana)insulinaModerada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

  • Levonorgestrel y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Levotiroxinahormona tiroideaModerada

    Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of somatropin. (etiqueta de Somatropina, Advertencias y precauciones)

  • Levotiroxina y liotironinahormona tiroideaModerada

    Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of somatropin. (etiqueta de Somatropina, Advertencias y precauciones)

  • Linagliptinainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Linagliptina y metforminainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Liotironinahormona tiroideaModerada

    Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of somatropin. (etiqueta de Somatropina, Advertencias y precauciones)

  • Liraglutidaagonista del receptor de GLP-1Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • MetforminabiguanidaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Metimazolfármaco antitiroideoModerada

    Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of somatropin. (etiqueta de Somatropina, Advertencias y precauciones)

  • MiglitolantidiabéticoModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • NateglinidameglitinidaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Norelgestromina y etinilestradiolestrógenoModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Noretisterona y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Norgestimato y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • Norgestrel y etinilestradiolanticonceptivo oralModerada

    Oral Estrogen Clinical Impact: Oral estrogens may reduce the serum IGF-1 response to HUMATROPE. (etiqueta de Somatropina, Interacciones medicamentosas)

  • PioglitazonatiazolidinedionaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Pioglitazona y glimepiridatiazolidinedionaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Pioglitazona y metforminatiazolidinedionaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Propiltiouracilofármaco antitiroideoModerada

    Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of somatropin. (etiqueta de Somatropina, Advertencias y precauciones)

  • RepaglinidameglitinidaModerada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Saxagliptinainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Saxagliptina y metforminainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Semaglutidaagonista del receptor de GLP-1Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Sitagliptinainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Sitagliptina y metforminainhibidor de la DPP-4Moderada

    The doses of antidiabetic agents may require adjustment when HUMATROPE is initiated. (etiqueta de Somatropina, Advertencias y precauciones)

  • Teriparatidahormona tiroideaModerada

    Hypothyroidism: Monitor thyroid function periodically as hypothyroidism may occur or worsen after initiation of somatropin. (etiqueta de Somatropina, Advertencias y precauciones)

  • Tirzepatidaagonista del receptor de GLP-1Moderada

    Glucose Intolerance and Diabetes Mellitus: HUMATROPE may decrease insulin sensitivity, particularly at higher doses. (etiqueta de Somatropina, Advertencias y precauciones)

Compruebe Somatropina frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.